Acasti Pharma | ACST - Ebitda

Stock Price
3.71
Daily Change
-0.04 -1.07%
Monthly
2.20%
Yearly
16.67%
Q1 Forecast
3.54

Acasti Pharma reported $-3.18M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
Acasti Pharma USD -3.18M 521K Mar/2025
Addus HomeCare USD 45.14M 1.22M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
Cassava Sciences USD -11.73M 33.44M Sep/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Option Care Health USD 119.5M 5.48M Sep/2025
Organigram Holdings CAD 6.15M 455K Sep/2025
Tilray USD 8.36M 1.82M Sep/2025